Method for preparing arginine-alpha-ketoglutaric acid by utilizing immobilized cells
By immobilizing E. coli cells on silica to form mixed bionic silica particles with core-shell structures, the problem of poor enzyme stability is solved, and the efficient preparation of α-ketoglutaric acid is achieved, the production cost is reduced, and industrialization is enhanced. Application potential.
Patent Information
- Application Number
- CN202411142587.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-08
AI Technical Summary
When the existing biological enzyme catalytic method is used to prepare α-ketoglutaric acid in industrialized production, the enzyme has poor stability and is difficult to reuse, resulting in high production costs and low efficiency.
Using immobilized cell technology, E. coli cells form a mixed bionic silica particle with core-shell structure on silica. Through polyethyleneimine-induced silicification method, immobilized cells with catalytic activity are formed to prepare arginine -α-ketoglutaric acid.
It improves the stability and reusability of enzymes, reduces production costs, and enhances the potential for industrial application.
Smart Images

Figure BDA0005001306070000051 
Figure BDA0005001306070000061 
Figure BDA0005001306070000062
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of bioenzyme engineering, and specifically relates to a method for preparing arginine-alpha-ketoglutarate by utilizing immobilized cells. Background Art
[0002] Arginine-alpha-ketoglutarate (AAKG), as an amino acid health product, AAKG is widely used. It can increase the production of nitric oxide in the body, which helps to dilate blood vessels and improve blood flow, thereby increasing the efficiency of oxygen and nutrient delivery, and improving muscle strength and endurance. In addition, AAKG can quickly provide nutrients to liver cells, help maintain liver function, and improve the prognosis of patients with liver disease. AAKG can also further improve athletic performance and recovery by enhancing protein synthesis in muscles and reducing protein breakdown. It is particularly beneficial for athletes and fitness enthusiasts because it can not only improve training performance, but also accelerate recovery and reduce muscle fatigue. Arginine-alpha-ketoglutarate can be generated by the reaction of arginine and alpha-ketoglutarate. However, alpha-ketoglutarate is relatively difficult to obtain, which to some extent limits the widespread application of AAKG.
[0003] α-ketoglutaric acid (AKG) is an organic acid that plays a key role in organisms and participates in the tricarboxylic acid cycle and amino acid metabolism. As an important dibasic acid, it plays a vital role in biochemical processes such as biological carbon and nitrogen metabolism, sugar metabolism, amino acid metabolism and protein synthesis, and has been widely used in food, medicine, cosmetics and animal feed. Because market demand far exceeds supply, its price is relatively high. This makes AKG a highly sought-after product that has received widespread attention and application. At present, there are three main methods for synthesizing AKG: organic chemical synthesis, microbial fermentation, and bio-enzyme catalysis.
[0004] At present, the industrial preparation of AKG mainly adopts the bio-enzyme catalysis method. However, enzyme catalysis technology still faces some limitations in industrial applications. The most prominent of these is the poor stability of free enzymes in catalytic reactions and the difficulty in reuse, which will significantly increase production costs and reduce production efficiency. The methods to solve the above problems can be divided into two categories. One is to use protein engineering methods to molecularly modify enzymes, and the other is to chemically modify or immobilize cells or enzymes. In recent years, more and more enzyme or cell immobilization technologies have been developed, which can effectively improve the stability of production catalysis. How to choose a suitable carrier to maintain the stability of the three-dimensional structure of the enzyme is the key to improving the economic benefits of enzyme preparations.
[0005] Microbial immobilization technology reduces the impact of the external environment on microorganisms by confining them to water-insoluble carriers, thereby improving the stability and reusability of microorganisms. This technology has been widely used in many fields, including simplifying product separation, reducing operating costs and resource recovery. In the immobilization operation, factors such as the characteristics of the immobilized material, preparation time, mechanical strength, and catalytic durability need to be considered. Immobilization methods include adsorption, covalent bonding, cross-linking, and embedding. Choosing the right method and carrier material is the key to the successful application of microbial immobilization technology. Summary of the invention
[0006] The purpose of the present invention is to provide a method for preparing arginine-α-ketoglutarate by using immobilized cells.
[0007] To achieve the above-mentioned purpose and other related purposes, the technical scheme provided by the present invention is: a method for preparing arginine-α-ketoglutarate using immobilized cells, wherein wet Escherichia coli cells are resuspended in phosphate buffer to obtain a cell suspension; silica, polyetherimide and hydrolyzed silica precursor are added to the cell suspension, stirred and then filtered to obtain HBSPs particles; the HBSPs particles are then placed in a glutaraldehyde solution to construct HBSPs with a core-shell structure; ultrapure water is used to prepare a sodium L-glutamate solution and an arginine solution with a pH of 7, and then the HBSPs particles are added to obtain a fermentation broth containing arginine-α-ketoglutarate after a catalytic reaction.
[0008] The preferred technical solution is: the preparation method of the hydrolyzed silicon dioxide precursor comprises: adding tetramethoxysilane to hydrochloric acid, and reacting at 20-28° C. for 10-40 minutes to obtain the silicon dioxide precursor.
[0009] The preferred technical solution is: the concentration of the tetramethoxysilane is 6 to 24 g / L.
[0010] The preferred technical solution is: in the cell suspension, the concentration of Escherichia coli wet cells is 5-40 g / L.
[0011] The preferred technical solution is: the concentration of silicon dioxide is 2-12 g / L; the concentration of polyetherimide is 1-6 g / L; in the catalytic reaction, the content of immobilized cells is 10-45 g / L.
[0012] The preferred technical solution is: the concentration of the catalytic reaction substrate sodium L-glutamate is 50-200 g / L.
[0013] The preferred technical solution is: the concentration of arginine as a substrate in the catalytic reaction is 60-240 g / L.
[0014] The preferred technical solution is: the catalytic reaction temperature is 20-45°C.
[0015] The preferred technical solution is: the pH value of the catalytic reaction is 3-9.
[0016] Due to the application of the above technical solution, the present invention has the following advantages compared with the prior art:
[0017] The present invention provides a method for preparing arginine-α-ketoglutarate using immobilized cells. By using a polyethyleneimine-induced silicification method, Escherichia coli engineered bacteria are immobilized on silica to form "hybrid biomimetic silica gel particles" with a core-shell structure, which have the potential for industrial application in biocatalytic production of AAKG. DETAILED DESCRIPTION
[0018] The following is a description of the implementation of the present invention by means of specific embodiments. Those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in the embodiments.
[0019] The following examples are provided for a better understanding of the present invention, but are not intended to limit the present invention. The experimental methods in the following examples are conventional methods unless otherwise specified. The experimental materials used in the following examples are purchased from conventional biochemical reagent stores unless otherwise specified.
[0020] Example 1: Cultivation of engineering bacteria
[0021] Take out the E. coli engineered bacteria stored in the glycerol tube and inoculate it into fresh LB medium at a 1% inoculation rate. Incubate overnight at 37°C and 220 rpm for 12 hours. Inoculate the overnight cultured bacteria into fresh LB medium at a 1% inoculation rate and incubate at 37°C and 200 rpm until OD reaches 0. 600 Reach 0.6-0.8. Next, add IPTG (isopropyl-β-D-thiogalactoside) with a final concentration of 0.4mM, and induce culture for 12 hours at 20°C and 180rpm. After the culture is completed, centrifuge at 4°C and 8000rpm for 10 minutes, discard the supernatant, and wash the precipitate three times with deionized water. Finally, the obtained Escherichia coli wet cells are frozen and stored at -20°C for use. The composition of the fermentation medium used is: 10g / L trypsin, 10g / L sodium chloride, 5g / L yeast extract, and the solvent is ultrapure water.
[0022] Example 2: Optimal concentration of immobilized material TMOS
[0023] At 25°C, TMOS was hydrolyzed with 0.1mM HCl solution (10g / L, 12g / L, 14g / L, 16g / L, 18g / L, 20g / L, 22g / L, 24g / L), and the reaction time was 30 minutes to obtain the hydrolyzed silica precursor. The E. coli wet cells (20g / L) collected in Example 1 were resuspended and stirred with 100mM phosphate buffer. Silica (6g / L), PEI (3g / L) and the hydrolyzed silica precursor were added to the cell suspension successively at 0h, 1h and 2h, respectively. Finally, it was stirred for 30 minutes, allowed to stand for 5 minutes, transferred to a Buchner funnel with filter paper, and HBSPs were separated by suction filtration. The particles were washed several times with deionized water and collected at 4°C. The obtained HBSPs particles were placed in a glutaraldehyde (GA, 20mM, 2g / L) solution to construct a multilayer structure. The cross-linking and siliconization processes were the same as the above preparation steps to obtain immobilized cells of engineered bacteria containing L-glutamate oxidase and catalase genes, which were stored in a refrigerator at 4°C for future use.
[0024] Definition of immobilized cell activity: In order to verify whether the cells will be damaged during the immobilization process, thereby affecting the activity and stability of the enzyme, flow cytometry can be used to measure the survival rate of cells after material encapsulation.
[0025] According to the above method, the obtained immobilized cell survival rate is as follows:
[0026] TMOS concentration (g / L) Survival rate (%) 10 71.4 12 79.6 14 86.2 16 92.3 18 99.1 20 96.1 22 89.0 24 75.2
[0027] Example 3: Optimal concentration of immobilized engineered bacteria
[0028] TMOS (18 g / L) was hydrolyzed with 0.1 mM HCl solution for 30 minutes at 25°C to obtain a hydrolyzed silica precursor. Next, the recombinant E. coli wet cells (5 g / L, 10 g / L, 15 g / L, 20 g / L, 25 g / L, 30 g / L, 35 g / L, 40 g / L) collected in Example 1 were resuspended with 100 mM phosphate buffer and stirred at 25°C. Silica (6 g / L), PEI (3 g / L) and the hydrolyzed silica precursor were added to the cell suspension successively at 0 h, 1 h and 2 h, respectively. Subsequently, the mixture was stirred for 30 minutes, allowed to stand for 5 minutes, transferred to a Buchner funnel with filter paper, and HBSPs were separated by suction filtration. The particles were washed several times with deionized water and collected at 4°C. The obtained HBSPs particles were placed in a glutaraldehyde (GA, 20 mM, 2 g / L) solution to construct a multilayer structure. The cross-linking and siliconization processes were the same as the above preparation steps, and the obtained engineered bacteria immobilized cells were finally stored in a 4°C refrigerator for future use.
[0029] According to the above method, the obtained immobilized cell survival rate is as follows:
[0030] Engineering bacteria cell concentration (g / L) Survival rate (%) 5 83.1 10 85.6 15 94.5 20 98.9 25 94.5 30 90.9 35 85.5 40 82.3
[0031] Example 4: Optimal concentration of immobilized material silica
[0032] At 25°C, TMOS (18 g / L) was hydrolyzed with 0.1 mM HCl solution for 30 minutes to obtain a hydrolyzed silica precursor. Next, the recombinant E. coli wet cells (20 g / L) collected in Example 1 were resuspended with 100 mM phosphate buffer and stirred at 25°C. Silica (2 g / L, 4 g / L, 6 g / L, 8 g / L, 10 g / L, 12 g / L), PEI (3 g / L) and the hydrolyzed silica precursor were added to the cell suspension at 0 h, 1 h and 2 h, respectively. Subsequently, the mixture was stirred for 30 minutes, allowed to stand for 5 minutes, transferred to a Buchner funnel with filter paper, and HBSPs were separated by suction filtration. The particles were washed several times with deionized water and collected at 4°C. The obtained HBSPs particles were placed in a glutaraldehyde (GA, 20 mM, 2 g / L) solution to construct a multilayer structure. The cross-linking and siliconization processes were the same as the above preparation steps, and the obtained engineered bacteria immobilized cells were finally stored in a 4°C refrigerator for future use.
[0033] According to the above method, the obtained immobilized cell survival rate is as follows:
[0034] Silica concentration (g / L) Survival rate (%) 2 79.3 4 84.7 6 98.4 8 94.6 10 88.9 12 85.3
[0035] Example 5: Optimal concentration of immobilized material PEI
[0036] At 25°C, TMOS (18 g / L) was hydrolyzed with 0.1 mM HCl solution for 30 minutes to obtain a hydrolyzed silica precursor. Next, the recombinant E. coli wet cells (20 g / L) collected in Example 1 were resuspended with 100 mM phosphate buffer and stirred at 25°C. Silica (6 g / L), PEI (1 g / L, 2 g / L, 2.0 g / L, 3 g / L, 4 g / L, 5 g / L, 6 g / L) and the hydrolyzed silica precursor were added to the cell suspension successively at 0 h, 1 h and 2 h, respectively. Subsequently, the mixture was stirred for 30 minutes, allowed to stand for 5 minutes, transferred to a Buchner funnel with filter paper, and HBSPs were separated by suction filtration. The particles were washed several times with deionized water and collected at 4°C. The obtained HBSPs particles were placed in a glutaraldehyde (GA, 20 mM, 2 g / L) solution to construct a multilayer structure. The cross-linking and siliconization processes were the same as the above preparation steps, and the obtained engineered bacteria immobilized cells were finally stored in a 4°C refrigerator for future use.
[0037] According to the above method, the obtained immobilized cell survival rate is as follows:
[0038] PEI concentration (g / L) Survival rate (%) 1 75.1 2 90.7 3 98.6 4 91.9 5 78.5 6 71.3
[0039] Example 6: Optimal immobilized cell concentration for immobilized cell catalytic reaction
[0040] Ultrapure water was used to prepare sodium L-glutamate and arginine solutions with a pH of 7, with concentrations of 100 g / L and 120 g / L, respectively. Then, the immobilized cell HBSPs (10 g / L, 15 g / L, 20 g / L, 25 g / L, 30 g / L, 35 g / L, 40 g / L, 45 g / L) with catalytic performance prepared in Example 5 were added to the solution. The catalytic reaction was carried out at 30°C and 200 rpm for 12 h.
[0041] Storage stability is crucial in the industrial application of microbial cells because it directly affects the service life of the cells. In order to study the storage performance of immobilized cells, the immobilized cells were placed in a refrigerator at 4°C for 12 days, recorded as 0-12 days. During this period, the residual catalytic activity of the cells was regularly measured and recorded.
[0042] According to the above method, the catalytic performance of the immobilized cells was measured as follows:
[0043]
[0044] Example 7: Optimal Substrate L-Glutamate Concentration for Immobilized Cell Catalytic Reaction
[0045] Ultrapure water was used to prepare sodium L-glutamate and arginine solutions with a pH of 7, the concentrations of sodium L-glutamate solutions were 50 g / L, 100 g / L, 150 g / L, and 200 g / L, and the concentration of arginine was 120 g / L. Then, HBSPs (25 g / L) with a core-shell structure having catalytic performance prepared in Example 5 were added to the solution. The catalytic reaction was carried out at 30°C and 200 rpm for 12 h.
[0046] According to the above method, the catalytic performance of the immobilized cells was measured as follows:
[0047]
[0048] Example 8: Optimal substrate arginine concentration for immobilized cell catalytic reaction
[0049] Ultrapure water was used to prepare sodium L-glutamate and arginine solutions with a pH of 7, the concentration of sodium L-glutamate solution was 100 g / L, and the concentration of arginine was 60 g / L, 120 g / L, 180 g / L, and 240 g / L, respectively. Then, HBSPs (25 g / L) with a core-shell structure having catalytic performance prepared in Example 5 were added to the solution. The catalytic reaction was carried out at 30°C and 200 rpm for 12 h.
[0050] According to the above method, the catalytic performance of the immobilized cells was measured as follows:
[0051]
[0052] Example 9: Optimum temperature for immobilized cell catalytic reaction
[0053] Ultrapure water was used to prepare sodium L-glutamate and arginine solutions with a pH of 7, with concentrations of 100 g / L and 120 g / L, respectively. Then, HBSPs (25 g / L) with a core-shell structure having catalytic performance prepared in Example 5 were added to the solution. The catalytic reaction was carried out at 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 200 rpm, and the reaction time was 12 h.
[0054] According to the above method, the catalytic performance of the immobilized cells was measured as follows:
[0055]
[0056]
[0057] Example 10: Optimal pH value for immobilized cell catalytic reaction
[0058] Ultrapure water was used to prepare sodium L-glutamate and arginine solutions with pH values of 3, 4, 5, 6, 7, 8, and 9, respectively, with concentrations of 100 g / L and 120 g / L, respectively. Then, HBSPs (25 g / L) with a core-shell structure having catalytic properties prepared in Example 4 were added to the solution. The catalytic reaction was carried out at 30° C. and 200 rpm for 12 h.
[0059] According to the above method, the catalytic performance of the immobilized cells was measured as follows:
[0060]
[0061] Example 10: A method for preparing arginine-α-ketoglutarate using immobilized cells
[0062] Cell immobilization: TMOS was hydrolyzed under 0.1mM HCl, and wet E. coli cells were resuspended in 100mM phosphate buffer. Silica, PEI, and hydrolyzed silicon precursors were added to the cell suspension in sequence, and then HBSPs particles were separated during stirring and filtration. These particles were then placed in a glutaraldehyde solution to construct a multilayer structure. HBSPs with a core-shell structure were obtained through crosslinking and silanization processes.
[0063] In the method of the present invention, factors such as the concentration of TMOS, PEI concentration, cell concentration, and the temperature and pH value during the catalytic reaction have a significant effect on the catalytic activity of HBSPs. Therefore, in order to achieve the best effect, the reaction conditions need to be accurately controlled within an appropriate range. This includes ensuring that the concentration of TMOS, PEI concentration, and cell concentration are within an ideal range, and maintaining an appropriate temperature and pH value during the catalytic reaction. Reasonable regulation of the concentration of TMOS can affect the silicification process, thereby affecting the structure and properties of HBSPs particles. Changes in PEI concentration may affect the formation of a multilayer structure of particles. Adjustment of cell concentration is directly related to the loading and distribution of HBSPs. In addition, changes in temperature and pH value during the catalytic reaction can also have a significant effect on the reaction kinetics and the activity of the enzyme.
[0064] According to some embodiments of the present invention, the concentration of TMOS is 14 g / L.
[0065] According to some embodiments of the invention, the cell concentration is 20 g / L.
[0066] According to some embodiments of the invention, the silica concentration is 4 g / L.
[0067] According to some embodiments of the present invention, the concentration of PEI is 2 g / L.
[0068] According to some embodiments of the present invention, the catalytic reaction immobilized cell content is 15 g / L.
[0069] According to some embodiments of the present invention, the concentration of the catalytic reaction substrate sodium L-glutamate is 50 g / L.
[0070] According to some embodiments of the present invention, the concentration of the catalytic reaction substrate arginine is 120 g / L.
[0071] According to some embodiments of the present invention, the catalytic reaction temperature is 25°C.
[0072] According to some embodiments of the present invention, the pH value of the catalytic reaction is 6.
[0073] Specifically, the wet cells are obtained by the following method:
[0074] (1) First, the glycerol tube bacteria were inoculated into a seed culture medium containing 50 μg / mL kanamycin. The culture conditions were 37°C, 200 rpm, and the culture time was 10-12 hours to obtain a seed solution with kanamycin resistance. The composition of the seed culture medium was: 10 g / L peptone, 10 g / L sodium chloride, 5 g / L yeast extract, and the solvent was ultrapure water.
[0075] (2) The obtained seed solution was inoculated into the fermentation medium at a volume concentration of 1%. The culture was carried out at 37°C and 200 rpm until the optical density (OD 600 ) until it reaches 0.6-0.8. Subsequently, add a final concentration of 0.4mM IPTG, adjust the culture conditions to 20°C, 180rpm, and continue induction for 12 hours. After the induction is completed, the fermentation broth is separated by centrifugation and the wet bacteria are collected. The composition of the fermentation medium is: 10g / L peptone, 10g / L sodium chloride, 5g / L yeast extract, and the solvent is ultrapure water.
[0076] The above description is only used to explain the preferred embodiments of the present invention, and is not intended to limit the present invention in any form. Therefore, any modifications or changes made to the present invention under the same inventive spirit should still be included in the scope of protection intended by the present invention.
Claims
1. A method for preparing arginine-α-ketoglutarate using immobilized cells, characterized in that: The wet cells of Escherichia coli are resuspended with phosphate buffer to obtain a cell suspension; silica, polyetherimide and hydrolyzed silica precursor are added to the cell suspension, stirred and then filtered to obtain HBSPs particles; the HBSPs particles are then placed in a glutaraldehyde solution to construct HBSPs with a core-shell structure; ultrapure water is used to prepare a sodium L-glutamate solution and an arginine solution with a pH of 7, and then the HBSPs particles are added to obtain a fermentation broth containing arginine-α-ketoglutarate after a catalytic reaction.
2. The method for preparing arginine-α-ketoglutarate using immobilized cells according to claim 1, characterized in that: The preparation method of the hydrolyzed silicon dioxide precursor comprises: adding tetramethoxysilane to hydrochloric acid, and reacting at 20-28° C. for 10-40 minutes to obtain the silicon dioxide precursor.
3. The method for preparing arginine-α-ketoglutarate using immobilized cells according to claim 2, characterized in that: The concentration of the tetramethoxysilane is 6-24 g / L.
4. The method for preparing arginine-α-ketoglutarate using immobilized cells according to claim 1, characterized in that: In the cell suspension, the concentration of Escherichia coli wet cells is 5-40 g / L.
5. The method for preparing arginine-α-ketoglutarate using immobilized cells according to claim 1, characterized in that: The concentration of silicon dioxide is 2-12 g / L; the concentration of polyetherimide is 1-6 g / L; and in the catalytic reaction, the content of immobilized cells is 10-45 g / L.
6. The method for preparing arginine-α-ketoglutarate using immobilized cells according to claim 1, characterized in that: The concentration of the catalytic reaction substrate sodium L-glutamate is 50-200 g / L.
7. The method for preparing arginine-α-ketoglutarate using immobilized cells according to claim 1, characterized in that: The concentration of arginine, a substrate in the catalytic reaction, is 60-240 g / L.
8. The method for preparing arginine-α-ketoglutarate using immobilized cells according to claim 1, characterized in that: The catalytic reaction temperature is 20-45°C.
9. The method for preparing arginine-α-ketoglutarate using immobilized cells according to claim 1, characterized in that: The pH value of the catalytic reaction is 3-9.
